1161 related articles for article (PubMed ID: 21512031)
41. YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (Review).
Jiang L; Li J; Zhang C; Shang Y; Lin J
Mol Med Rep; 2020 Nov; 22(5):4101-4106. PubMed ID: 33000236
[TBL] [Abstract][Full Text] [Related]
42. The phosphoinositide PI5P inhibits the Hippo pathway effector YAP.
Baumann K
Nat Rev Mol Cell Biol; 2024 Jul; 25(7):513. PubMed ID: 38858473
[No Abstract] [Full Text] [Related]
43. Hippo signaling regulates pancreas development through inactivation of Yap.
George NM; Day CE; Boerner BP; Johnson RL; Sarvetnick NE
Mol Cell Biol; 2012 Dec; 32(24):5116-28. PubMed ID: 23071096
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of β1-AR/Gαs signaling promotes cardiomyocyte proliferation in juvenile mice through activation of RhoA-YAP axis.
Sakabe M; Thompson M; Chen N; Verba M; Hassan A; Lu R; Xin M
Elife; 2022 Dec; 11():. PubMed ID: 36479975
[TBL] [Abstract][Full Text] [Related]
45. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.
Lu L; Finegold MJ; Johnson RL
Exp Mol Med; 2018 Jan; 50(1):e423. PubMed ID: 29303509
[TBL] [Abstract][Full Text] [Related]
46. [Role of the Hippo pathway in cell proliferation and organ size control. Disorders of the pathway in cancer diseases].
Rybarczyk A; Wierzbicki P; Kowalczyk A; Kmieć Z
Postepy Hig Med Dosw (Online); 2014 May; 68():503-15. PubMed ID: 24864102
[TBL] [Abstract][Full Text] [Related]
47. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
[TBL] [Abstract][Full Text] [Related]
48. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.
Azzolin L; Panciera T; Soligo S; Enzo E; Bicciato S; Dupont S; Bresolin S; Frasson C; Basso G; Guzzardo V; Fassina A; Cordenonsi M; Piccolo S
Cell; 2014 Jul; 158(1):157-70. PubMed ID: 24976009
[TBL] [Abstract][Full Text] [Related]
49. The role of the Hippo pathway in autophagy in the heart.
Maejima Y; Zablocki D; Nah J; Sadoshima J
Cardiovasc Res; 2023 Jan; 118(17):3320-3330. PubMed ID: 35150237
[TBL] [Abstract][Full Text] [Related]
50. Hippo-yap signaling in ocular development and disease.
Lee M; Goraya N; Kim S; Cho SH
Dev Dyn; 2018 Jun; 247(6):794-806. PubMed ID: 29532607
[TBL] [Abstract][Full Text] [Related]
51. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
Hao Y; Chun A; Cheung K; Rashidi B; Yang X
J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
[TBL] [Abstract][Full Text] [Related]
52. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.
Lee KP; Lee JH; Kim TS; Kim TH; Park HD; Byun JS; Kim MC; Jeong WI; Calvisi DF; Kim JM; Lim DS
Proc Natl Acad Sci U S A; 2010 May; 107(18):8248-53. PubMed ID: 20404163
[TBL] [Abstract][Full Text] [Related]
53. Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development.
Xiao Y; Hill MC; Zhang M; Martin TJ; Morikawa Y; Wang S; Moise AR; Wythe JD; Martin JF
Dev Cell; 2018 Apr; 45(2):153-169.e6. PubMed ID: 29689192
[TBL] [Abstract][Full Text] [Related]
54.
Nantie LB; Young RE; Paltzer WG; Zhang Y; Johnson RL; Verheyden JM; Sun X
Development; 2018 Nov; 145(21):. PubMed ID: 30305289
[TBL] [Abstract][Full Text] [Related]
55. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development.
Bergmann MW
Circ Res; 2010 Nov; 107(10):1198-208. PubMed ID: 21071717
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
57. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
58. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia.
Chorzalska A; Kim JF; Roder K; Tepper A; Ahsan N; Rao RSP; Olszewski AJ; Yu X; Terentyev D; Morgan J; Treaba DO; Zhao TC; Liang O; Gruppuso PA; Dubielecka PM
Stem Cells Dev; 2017 May; 26(9):656-677. PubMed ID: 28103766
[TBL] [Abstract][Full Text] [Related]
59. Deregulation of the Hippo Pathway Promotes Tumor Cell Proliferation Through YAP Activity in Human Sporadic Vestibular Schwannoma.
Zhao F; Yang Z; Chen Y; Zhou Q; Zhang J; Liu J; Wang B; He Q; Zhang L; Yu Y; Liu P
World Neurosurg; 2018 Sep; 117():e269-e279. PubMed ID: 29902598
[TBL] [Abstract][Full Text] [Related]
60. αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.
Li P; Silvis MR; Honaker Y; Lien WH; Arron ST; Vasioukhin V
Genes Dev; 2016 Apr; 30(7):798-811. PubMed ID: 27013234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
